Absci (NASDAQ: ABSI) net income
Absci reported a net loss of $115.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $103.1m. Earnings per share were −$0.84.
Absci's best year of the last 6 was fiscal 2020. It reported a loss in 6 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$115.2m | — | −4,113.7% | −$0.84 |
| 2024 | −$103.1m | — | −2,274.1% | −$0.94 |
| 2023 | −$110.6m | — | −1,933.6% | −$1.20 |
| 2022 | −$104.9m | — | −1,825.4% | −$1.15 |
| 2021 | −$101.0m | — | −2,111.3% | −$2.08 |
| 2020 | −$14.4m | — | −300.3% | −$3.19 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Absci net income compared with its sector
By net income for its latest fiscal year, Absci ranks 351st of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Absci, −4,113.7%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 349th | IDEAYA Biosciences | −$113.7m | −52.0% |
| 350th | MeiraGTx | −$114.2m | −140.3% |
| 351st | Absci | −$115.2m | −4,113.7% |
| 352nd | Korro Bio | −$117.3m | −1,834.5% |
| 353rd | Savara | −$118.8m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Absci
- How much did Absci earn in fiscal 2025?
- Absci reported a net loss of $115.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $103.1m.
- What are the earnings per share of Absci?
- They were −$0.84 in fiscal 2025, compared with −$0.94 in fiscal 2024.
- Where does Absci rank in its sector by net income?
- It ranks 351st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Absci come from?
- From the annual report (Form 10-K) that Absci files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Absci files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Absci: the Absci page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.